Screening And Structural Characterization Of Potential Alpha-Glucosidase Inhibitors From Radix Astragali Flavonoids Extract By Ultrafiltration Lc-Dad-Esi-Msn

Wenyue Jiang,Hong Kan,Pengdong Li,Shu Liu,Zhongying Liu
DOI: https://doi.org/10.1039/c4ay02081b
IF: 3.1
2015-01-01
Analytical Methods
Abstract:Inhibition of intestinal alpha-glucosidase activity is one important mechanism for the management of diabetes mellitus (DM). Identifying plants with alpha-glucosidase inhibitory activities and screening active compounds (alpha-glucosidase inhibitors) in them has become a popular field of research in the treatment of DM. In the present study, we used an in vitro assay of ultraviolet spectrophotometry to evaluate the a-glucosidase inhibitory activity of Radix Astragali flavonoids extract (RAFE). Then, ultrafiltration liquid chromatography with photodiode array detection coupled to electrospray ionization tandem mass spectrometry (ultrafiltration LC-DAD-ESI-MSn) was used to screen the active compounds in RAFE. As a result, the concentration (final) of RAFE required for 50% enzyme inhibition (IC50) was calculated as 2.888 mg mL(-1). Through ultrafiltration LC-DAD-ESI-MSn analysis, seven compounds were identified as potential active compounds. They were calycosin-7-O-beta-D-glucoside, biochanin A, calycosin-7-O-beta-D-glucoside-6 ''-O-malonate, ononin, calycosin, formononetin-7-O-beta-D-glucoside-6 ''-O-malonate and formononetin. Then, two of the potential active compounds, biochanin A and formononetin, were evaluated for alpha-glucosidase inhibitory activity. Their IC50 values were calculated as 0.020 mM and 0.027 mM respectively, while that of the reference drug acarbose was calculated as 0.382 mM.
What problem does this paper attempt to address?